| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2017 | Hayden Donald J Jr | Director | Sale+OE | 40,000 | $28.70 | $1,148,000.00 | -100% | |
| Sep 15, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $27.39 | $136,925.26 | -2.5% | |
| Sep 8, 2017 | Yoo Stephen | Chief Medical Officer | Sale+OE | 27,342 | $25.00 | $683,550.00 | -100% | |
| Sep 6, 2017 | Yoo Stephen | Chief Medical Officer | Sale+OE | 32,658 | $25.00 | $816,450.00 | -100% | |
| Sep 5, 2017 | Hayden Donald J Jr | Director | Sale+OE | 20,000 | $24.95 | $499,000.00 | -100% | |
| Sep 5, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 10,500 | $25.00 | $262,500.00 | -8.1% | |
| Aug 21, 2017 | Yoo Stephen | Chief Medical Officer | Sale+OE | 15,000 | $20.03 | $300,450.00 | -100% | |
| Aug 21, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 6,500 | $20.05 | $130,325.00 | -5.8% | |
| Aug 15, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,040 | $21.09 | $64,110.85 | -1.5% | |
| Jul 20, 2017 | Yoo Stephen | Chief Medical Officer | Sale+OE | 15,000 | $18.66 | $279,900.00 | -100% |